Overweight and Obesity in Patients with Congenital Heart Disease: A Systematic Review.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
21 09 2021
Historique:
received: 30 08 2021
revised: 17 09 2021
accepted: 18 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 10 2021
Statut: epublish

Résumé

Overweight and obesity have become a major public health concern in recent decades, particularly in patients with chronic health conditions like congenital heart disease (CHD). This systematic review elaborates on the prevalence and the longitudinal development of overweight and obesity in children and adults with CHD. A systematic literature search was conducted in PubMed, Cochrane, and Scopus from January 2010 to December 2020 on overweight and obesity prevalence in children and adults with CHD. Of 30 included studies, 15 studies evaluated 5680 pediatric patients with CHD, 9 studies evaluated 6657 adults with CHD (ACHD) and 6 studies examined 9273 both pediatric patients and ACHD. Fifteen studies received the quality rating "good", nine studies "fair", and six studies "poor". In children with CHD, overweight prevalence was between 9.5-31.5%, and obesity prevalence was between 9.5-26%; in ACHD, overweight prevalence was between 22-53%, and obesity was between 7-26%. The prevalence of overweight and obesity was thereby similar to the general population. Overweight and obesity have been shown to increase with age. The prevalence of overweight and obesity in children and adults with CHD is similar to the general population, demonstrating that the growing obesity pandemic is also affecting the CHD population.

Sections du résumé

BACKGROUND
Overweight and obesity have become a major public health concern in recent decades, particularly in patients with chronic health conditions like congenital heart disease (CHD). This systematic review elaborates on the prevalence and the longitudinal development of overweight and obesity in children and adults with CHD.
METHODS
A systematic literature search was conducted in PubMed, Cochrane, and Scopus from January 2010 to December 2020 on overweight and obesity prevalence in children and adults with CHD.
RESULTS
Of 30 included studies, 15 studies evaluated 5680 pediatric patients with CHD, 9 studies evaluated 6657 adults with CHD (ACHD) and 6 studies examined 9273 both pediatric patients and ACHD. Fifteen studies received the quality rating "good", nine studies "fair", and six studies "poor". In children with CHD, overweight prevalence was between 9.5-31.5%, and obesity prevalence was between 9.5-26%; in ACHD, overweight prevalence was between 22-53%, and obesity was between 7-26%. The prevalence of overweight and obesity was thereby similar to the general population. Overweight and obesity have been shown to increase with age.
CONCLUSION
The prevalence of overweight and obesity in children and adults with CHD is similar to the general population, demonstrating that the growing obesity pandemic is also affecting the CHD population.

Identifiants

pubmed: 34574853
pii: ijerph18189931
doi: 10.3390/ijerph18189931
pmc: PMC8466650
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Circulation. 2017 Aug 22;136(8):704-718
pubmed: 28626087
Heart Lung. 2020 Nov - Dec;49(6):788-794
pubmed: 32980629
Heart. 2014 Nov;100(21):1702-7
pubmed: 24973081
J Cardiovasc Nurs. 2013 Jan-Feb;28(1):66-73
pubmed: 22210143
Eur Heart J. 2010 May;31(10):1220-9
pubmed: 20207625
Pediatr Cardiol. 2012 Jun;33(5):705-12
pubmed: 22314368
Cardiol Young. 2014 Oct;24(5):848-53
pubmed: 24067132
Can J Cardiol. 2015 Feb;31(2):117-23
pubmed: 25573090
J Am Heart Assoc. 2016 Feb 12;5(2):
pubmed: 26873680
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Heart. 2017 Aug;103(16):1250-1257
pubmed: 28237971
J Am Coll Cardiol. 2010 Sep 28;56(14):1149-57
pubmed: 20863956
Congenit Heart Dis. 2015 Sep-Oct;10(5):447-56
pubmed: 25385245
Am J Cardiol. 2012 Jun 1;109(11):1657-63
pubmed: 22444325
BMC Pediatr. 2014 Oct 16;14:271
pubmed: 25323400
J Am Heart Assoc. 2020 Dec 15;9(24):e018345
pubmed: 33289459
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
Circulation. 2015 Dec 1;132(22):2118-25
pubmed: 26369353
Circulation. 2016 Feb 16;133(7):639-49
pubmed: 26746176
Arterioscler Thromb Vasc Biol. 2007 May;27(5):996-1003
pubmed: 17303782
J Can Acad Child Adolesc Psychiatry. 2011 Feb;20(1):57-9
pubmed: 21286370
World J Pediatr Congenit Heart Surg. 2018 Mar;9(2):177-184
pubmed: 29544424
JAMA. 2010 Nov 10;304(18):2042-7
pubmed: 21063014
J Am Heart Assoc. 2014 Oct 30;3(6):e001076
pubmed: 25359401
Pediatr Cardiol. 2016 Jan;37(1):192-200
pubmed: 26377100
Congenit Heart Dis. 2019 May;14(3):479-486
pubmed: 30681771
Cardiol Young. 2015 Aug;25(6):1044-53
pubmed: 25247327
Int J Cardiol. 2015;187:219-26
pubmed: 25838217
J Cardiovasc Nurs. 2020 May/Jun;35(3):291-299
pubmed: 32221146
Eur J Clin Nutr. 2015 Oct;69(10):1105-8
pubmed: 25920422
J Cardiovasc Nurs. 2019 Jan/Feb;34(1):71-75
pubmed: 30211814
Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):367-377
pubmed: 30795994
J Pediatr. 2014 May;164(5):1074-1078.e1
pubmed: 24607241
BMC Cardiovasc Disord. 2020 May 19;20(1):231
pubmed: 32429858
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Paediatr Perinat Epidemiol. 2012 Jul;26(4):336-43
pubmed: 22686385
An Pediatr (Engl Ed). 2019 Feb;90(2):102-108
pubmed: 29691131
Am J Cardiol. 2017 Feb 15;119(4):638-642
pubmed: 27931725
Cardiol Young. 2019 Feb;29(2):123-127
pubmed: 30785381
Cardiol Young. 2020 Mar;30(3):372-376
pubmed: 31915104
Am J Cardiol. 2017 Jan 1;119(1):112-118
pubmed: 28247847
Cardiol Young. 2011 Dec;21(6):603-7
pubmed: 21733340
Lancet. 2011 Aug 27;378(9793):804-14
pubmed: 21872749
Congenit Heart Dis. 2019 Jul;14(4):549-558
pubmed: 31099471
Cardiol Young. 2017 Jul;27(5):890-894
pubmed: 27655153
Can J Cardiol. 2015 Feb;31(2):109-11
pubmed: 25661546
Congenit Heart Dis. 2019 Jul;14(4):517-524
pubmed: 30698365
Congenit Heart Dis. 2018 Jul;13(4):563-570
pubmed: 29938932

Auteurs

Laura Willinger (L)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.

Leon Brudy (L)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.

Michael Meyer (M)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.

Renate Oberhoffer-Fritz (R)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.
Institute of Preventive Pediatrics, Technische Universität München, 80992 Munich, Germany.

Peter Ewert (P)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80636 Munich, Germany.

Jan Müller (J)

Department of Congenital Heart Disease and Pediatric Cardiology, Deutsches Herzzentrum München, Technische Universität München, 80636 Munich, Germany.
Institute of Preventive Pediatrics, Technische Universität München, 80992 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH